Other
AstraZeneca to pay about $260M for Omthera Pharma (Update 2)
British drugmaker AstraZeneca PLC plans to spend about $260 million on Omthera Pharmaceuticals Inc., a specialty drug developer with only 14 employees but has a potential treatment for patients who have high levels of fats ...
May 28, 2013
0
0